November 4, 2025

Pharmaceutical giants AstraZeneca, Eli Lilly & Co. and Merck & Co. have committed a cumulative $120 million to develop a workforce training center for advanced pharmaceutical manufacturing in Central Virginia.

The companies, each of which is planning to build manufacturing facilities in Virginia; the state government, including Virginia Innovation Partnership Corp.; and multiple Virginia colleges and universities entered into a memorandum of understanding to establish the center, which Gov. Glenn Youngkin signed at an event announcing the partnership on Friday.


Dubbed the Virginia Center for Advanced Pharmaceutical Manufacturing, the workforce...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) today announced the first clinical xenotransplantation in its EXPAND study of the UKidney™ in patients with end-stage renal disease (ESRD). The successful transplant operation was performed at NYU Langone Health.

United Therapeutics’ UKidney is an investigational xenokidney from a pig with 10 gene edits. Six human genes are added to the...

COLUMBIA, Md., (November 3, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced the winner for the Concept Capital Pitch Competition, BioEvanesce. The pitch competition gave these founders the chance to obtain an additional $25,000 at the 2025 Entrepreneur Expo.

“The Concept Capital Pitch Competition offered more than just potential funding to the competitors – it provided a chance to practice pitching, receive real-time feedback from expert judges and connect with interested audiences,” said TEDCO CEO Troy LeMaile-Stovall. “We...

BHI Entrepreneur-in-Residence Dr. Kevin Heller joins A Dose of Reality with Charles Spence to share insights from his journey as a former biotech CMO and now trusted advisor to venture funds and early-stage biotechs.

In this episode, Kevin discusses his role as an Entrepreneur-in-Residence at BHI, how he supports companies and investors on strategy, and what he’s learned about leadership, culture, and resilience throughout his career. He also offers a candid look at today’s funding climate—why raising capital feels tougher than ever, what investors are truly looking for, and how founders can prepare for the unexpected.

In this episode of BioTalk, Rich Bendis sits down with Councilman Brian Knudsen, Jamie Schwartz of UNLV, and Vance Farrow from the Nevada Governor’s Office of Economic Development to spotlight the rapid emergence of Southern Nevada as a rising force in the biohealth landscape. The conversation covers the launch of the $10 million BioHealth Innovation Challenge, the Desert Forge Venture Fund, and the revitalization of BioTech Vegas—all designed to attract industry anchors, fuel early-stage startups, and cultivate a thriving innovation ecosystem. They also explore how strong collaboration...

WASHINGTON , DC, UNITED STATES, October 29, 2025 /EINPresswire.com/ -- The Indo US Organization for Rare Diseases (IndoUSrare) proudly announces the Indo US Bridging RARE Summit 2025, taking place November 2–4, 2025, at the Hylton Performing Arts Center, George Mason University in Manassas, Virginia. This premier hybrid event will bring together patients, scientists, policymakers, clinicians, innovators, investors, and advocates from across the United States, India, and around the world, working together to accelerate the discovery and accessibility of therapies for millions living with rare diseases.

VENLO, Netherlands, & GERMANTOWN, Maryland--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the 4,000th placement of its QIAcube Connect instrument, a significant milestone in driving automation adoption for sample processing across life science and diagnostic labs.

This accomplishment is underscored by the nearly 13,000 cumulative placements of QIAcube platforms globally since launch, and evidence of widespread trust given more than 29,900 cumulative placements of QIAGEN Sample...

Healthcare is setting the pace for enterprise AI adoption.

Long dismissed as a digital laggard that trailed years behind every major innovation wave, healthcare has flipped the script. The $4.9 trillion industry,1 which represents one-fifth of the U.S. economy2 but accounts for only 12% percent of software spend,3 is now deploying AI at more than twice the rate (2.2x) of the broader economy. The transformation happened fast. In just two years, healthcare went from 3% adoption to becoming America’s AI powerhouse. Health systems are leading the charge at 27%, outpacing outpatient facilities (18%) and payers (14%).

According to Menlo...

ROCKVILLE, Md., Oct. 30, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the completion of enrollment in the AFFINITY DUCHENNE® pivotal trial of RGX-202, an investigational gene therapy for the treatment of Duchenne muscular dystrophy, as well as the successful production of the first batches intended for commercial supply.

"The Duchenne community urgently needs new treatment options that provide durable, safe outcomes and can meaningfully change the course of this degenerative disease...

FREDERICK, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that Carsten Brunn, Ph.D., was named as Chairman of the Board of Directors, effective October 29, 2025. Dr. Brunn, who currently serves as the Company’s President and Chief Executive Officer and as a member of the Board, will succeed Carrie S. Cox, who is...